Stephanie Vos
Stephanie Vos
Department of Psychiatry and Neuropsychology, Maastricht University
Verified email at maastrichtuniversity.nl - Homepage
Title
Cited by
Cited by
Year
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
6522015
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
SJB Vos, C Xiong, PJ Visser, MS Jasielec, J Hassenstab, EA Grant, ...
The Lancet Neurology 12 (10), 957-965, 2013
4092013
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ...
Brain 138 (5), 1327-1338, 2015
1852015
Suspected non-Alzheimer disease pathophysiology—concept and controversy
CR Jack Jr, DS Knopman, G Chételat, D Dickson, AM Fagan, GB Frisoni, ...
Nature Reviews Neurology 12 (2), 117, 2016
1612016
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
SJB Vos, IA Van Rossum, F Verhey, DL Knol, H Soininen, LO Wahlund, ...
Neurology 80 (12), 1124-1132, 2013
1172013
Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design
IA van Rossum, S Vos, R Handels, PJ Visser
Journal of Alzheimer's Disease 20 (3), 881-891, 2010
1122010
Injury markers predict time to dementia in subjects with MCI and amyloid pathology
IA van Rossum, SJB Vos, L Burns, DL Knol, P Scheltens, H Soininen, ...
Neurology 79 (17), 1809-1816, 2012
1102012
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
S Vos, I van Rossum, L Burns, D Knol, P Scheltens, H Soininen, ...
Neurobiology of aging 33 (10), 2272-2281, 2012
882012
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World …
P Lewczuk, P Riederer, SE O’Bryant, MM Verbeek, B Dubois, PJ Visser, ...
The world journal of biological psychiatry 19 (4), 244-328, 2018
832018
Inflammatory events at blood–brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease
HE de Vries, G Kooij, D Frenkel, S Georgopoulos, A Monsonego, ...
Epilepsia 53, 45-52, 2012
672012
Comparison of international working group criteria and national institute on Aging–Alzheimer’s association criteria for Alzheimer’s disease
PJ Visser, S Vos, I van Rossum, P Scheltens
Alzheimer's & Dementia 8 (6), 560-563, 2012
652012
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia
WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ...
JAMA psychiatry 75 (1), 84-95, 2018
632018
Variability of CSF Alzheimer’s disease biomarkers: implications for clinical practice
SJB Vos, PJ Visser, F Verhey, P Aalten, D Knol, I Ramakers, P Scheltens, ...
PloS one 9 (6), 2014
602014
NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers
SJB Vos, BA Gordon, Y Su, PJ Visser, DM Holtzman, JC Morris, ...
Neurobiology of aging 44, 1-8, 2016
532016
Modifiable risk factors for prevention of dementia in midlife, late life and the oldest-old: validation of the LIBRA Index
SJB Vos, MPJ Van Boxtel, OJG Schiepers, K Deckers, M De Vugt, ...
Journal of Alzheimer's Disease 58 (2), 537-547, 2017
322017
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ...
Alzheimer's & Dementia 15 (3), 465-476, 2019
292019
Lifestyle for Brain Health (LIBRA): a new model for dementia prevention
OJG Schiepers, S Köhler, K Deckers, K Irving, CA O'Donnell, ...
International journal of geriatric psychiatry 33 (1), 167-175, 2018
232018
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers
RLH Handels, SJB Vos, MG Kramberger, V Jelic, K Blennow, ...
Alzheimer's & Dementia 13 (8), 903-912, 2017
212017
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
I Bos, FR Verhey, IHGB Ramakers, HIL Jacobs, H Soininen, ...
Alzheimer's research & therapy 9 (1), 101, 2017
202017
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
N Mattsson, C Groot, WJ Jansen, SM Landau, VL Villemagne, ...
Alzheimer's & Dementia 14 (7), 913-924, 2018
192018
The system can't perform the operation now. Try again later.
Articles 1–20